132 related articles for article (PubMed ID: 26687579)
21. Docetaxel prodrug self-assembled nanosystem: Synthesis, formulation and cytotoxicity.
Jing F; Guo Q; Xu W; Qu H; Sui Z
Bioorg Med Chem Lett; 2018 Feb; 28(4):826-830. PubMed ID: 29395972
[TBL] [Abstract][Full Text] [Related]
22. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity.
Wang L; Liu Z; Liu D; Liu C; Juan Z; Zhang N
Int J Pharm; 2011 Jul; 413(1-2):194-201. PubMed ID: 21540085
[TBL] [Abstract][Full Text] [Related]
23. Tumor pH(e)-triggered charge-reversal and redox-responsive nanoparticles for docetaxel delivery in hepatocellular carcinoma treatment.
Chen F; Zhang J; Wang L; Wang Y; Chen M
Nanoscale; 2015 Oct; 7(38):15763-79. PubMed ID: 26355843
[TBL] [Abstract][Full Text] [Related]
24. Tumor-specific delivery and therapy by double-targeted DTX-CMCS-PEG-NGR conjugates.
Liu F; Li M; Liu C; Liu Y; Liang Y; Wang F; Zhang N
Pharm Res; 2014 Feb; 31(2):475-88. PubMed ID: 24043295
[TBL] [Abstract][Full Text] [Related]
25. Polysaccharide dextran-based conjugate for selective co-delivery of two synergistic drugs docetaxel and docosahexaenoic acid to tumor cells.
Dong P; Lv H; Jia W; Liu J; Wang S; Li X; Hu J; Zhao L; Shi Y
Drug Deliv; 2023 Dec; 30(1):40-50. PubMed ID: 36458324
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, in vitro characterization, and anti-tumor effects of novel polystyrene-poly(amide-ether-ester-imide) co-polymeric micelles for delivery of docetaxel in breast cancer in Balb/C mice.
Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Mirsafaei R
Drug Dev Ind Pharm; 2018 Jul; 44(7):1139-1157. PubMed ID: 29436875
[TBL] [Abstract][Full Text] [Related]
27. Dextran-PLGA-loaded docetaxel micelles with enhanced cytotoxicity and better pharmacokinetic profile.
Raza K; Kumar N; Misra C; Kaushik L; Guru SK; Kumar P; Malik R; Bhushan S; Katare OP
Int J Biol Macromol; 2016 Jul; 88():206-12. PubMed ID: 27037052
[TBL] [Abstract][Full Text] [Related]
28. Synthetic modification of carboxymethylcellulose and use thereof to prepare a nanoparticle forming conjugate of docetaxel for enhanced cytotoxicity against cancer cells.
Ernsting MJ; Tang WL; MacCallum N; Li SD
Bioconjug Chem; 2011 Dec; 22(12):2474-86. PubMed ID: 22014112
[TBL] [Abstract][Full Text] [Related]
29. Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery.
Thambi T; You DG; Han HS; Deepagan VG; Jeon SM; Suh YD; Choi KY; Kim K; Kwon IC; Yi GR; Lee JY; Lee DS; Park JH
Adv Healthc Mater; 2014 Nov; 3(11):1829-38. PubMed ID: 24753360
[TBL] [Abstract][Full Text] [Related]
30. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.
Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z
Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952
[TBL] [Abstract][Full Text] [Related]
31. Dual Stimuli-Responsive Hybrid Polymeric Nanoparticles Self-Assembled from POSS-Based Starlike Copolymer-Drug Conjugates for Efficient Intracellular Delivery of Hydrophobic Drugs.
Yang Q; Li L; Sun W; Zhou Z; Huang Y
ACS Appl Mater Interfaces; 2016 Jun; 8(21):13251-61. PubMed ID: 27167898
[TBL] [Abstract][Full Text] [Related]
32. Docetaxel prodrug liposomes for tumor therapy: characterization, in vitro and in vivo evaluation.
Ren G; Liu D; Guo W; Wang M; Wu C; Guo M; Ai X; Wang Y; He Z
Drug Deliv; 2016 May; 23(4):1272-81. PubMed ID: 26965023
[TBL] [Abstract][Full Text] [Related]
33. Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors.
Senthilkumar M; Mishra P; Jain NK
J Drug Target; 2008 Jun; 16(5):424-35. PubMed ID: 18569287
[TBL] [Abstract][Full Text] [Related]
34. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer.
Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT
Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252
[TBL] [Abstract][Full Text] [Related]
35. Zwitterionic mesoporous nanoparticles with a bioresponsive gatekeeper for cancer therapy.
Khatoon S; Han HS; Lee M; Lee H; Jung DW; Thambi T; Ikram M; Kang YM; Yi GR; Park JH
Acta Biomater; 2016 Aug; 40():282-292. PubMed ID: 27063494
[TBL] [Abstract][Full Text] [Related]
36. Novel pH-sensitive nanoformulated docetaxel as a potential therapeutic strategy for the treatment of cholangiocarcinoma.
Du N; Song LP; Li XS; Wang L; Wan L; Ma HY; Zhao H
J Nanobiotechnology; 2015 Feb; 13():17. PubMed ID: 25889600
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and tissue distribution of docetaxel by liquid chromatography-mass spectrometry: evaluation of folate receptor-targeting amphiphilic copolymer modified nanostructured lipid carrier.
Zhao X; Zhao Y; Geng L; Li X; Wang X; Liu Z; Wang D; Bi K; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Dec; 879(31):3721-7. PubMed ID: 22035980
[TBL] [Abstract][Full Text] [Related]
38. Nanoparticulated docetaxel exerts enhanced anticancer efficacy and overcomes existing limitations of traditional drugs.
Choi J; Ko E; Chung HK; Lee JH; Ju EJ; Lim HK; Park I; Kim KS; Lee JH; Son WC; Lee JS; Jung J; Jeong SY; Song SY; Choi EK
Int J Nanomedicine; 2015; 10():6121-32. PubMed ID: 26457052
[TBL] [Abstract][Full Text] [Related]
39. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles.
Tong SW; Xiang B; Dong DW; Qi XR
Int J Pharm; 2012 Sep; 434(1-2):413-9. PubMed ID: 22698861
[TBL] [Abstract][Full Text] [Related]
40. Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo.
Alibolandi M; Abnous K; Hadizadeh F; Taghdisi SM; Alabdollah F; Mohammadi M; Nassirli H; Ramezani M
J Control Release; 2016 Nov; 241():45-56. PubMed ID: 27639681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
